Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery

NCT03233607 | Completed

• 1 other identifier: AAAR4466
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).

Conditions

Hemorrhage, Postpartum

Keywords

Postpartum; Hemoglobin

Outcome Measures

Primary Outcomes (3)

• Change in maternal hemoglobin

  Maternal hemoglobin will be measured on postpartum day 1 to day 2

  Day 1 and Day 2

• Correlation of maternal hemoglobin to EBL

  Maternal hemoglobin will be measured to assess correlation to visually estimated blood loss

  Up to 2 days after delivery

• Correlation of maternal hemoglobin to QBL

  Maternal hemoglobin will be measured to assess correlation to quantified blood loss

  Up to 2 days after delivery

Study Arms (1)

Antepartum Patients

Includes antepartum patients receiving prenatal care at the Broadway Practice who plan to deliver at Allen Hospital in New York City (NYC). On postpartum day 1 and day 2, a sample of blood will be drawn in the morning for hemoglobin and hematocrit estimation.

Procedure: Blood Draw

Interventions

Blood Draw PROCEDURE

On postpartum day 1 and day 2, a sample of blood will be drawn in the morning for hemoglobin and hematocrit estimation.

Antepartum Patients

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant women who are admitted to the Allen hospital for delivery during the recruitment period.

You may qualify if:

• All antepartum patients receiving prenatal care at the Broadway Practice and plan to deliver at Allen Hospital in NYC.

You may not qualify if:

• Patients who gave consent to participate in the study but did not deliver at Allen hospital.

Sponsors & Collaborators

• Columbia University: lead

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Postpartum Hemorrhage

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Obstetric Labor Complications; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Puerperal Disorders; Uterine Hemorrhage; Hemorrhage; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Surgical Procedures, Operative; Investigative Techniques

Study Officials

• Rachana Gavara, MD

  Columbia University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor of Obstetrics and Gynecology

Study Record Dates

• First Submitted: July 26, 2017
• First Posted: July 28, 2017
• Study Start: March 20, 2018
• Primary Completion: January 4, 2019
• Study Completion: April 23, 2019
• Last Updated: April 24, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)